International Psoriasis Council
Advancing Knowledge. Improving Care.
The IPC Virtual Psoriasis Masterclass is designed for early career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
There is no cost to attend the program, but space is limited. The application deadline is May 5, 2025.
Timezones:
Tijuana: 11:00 – 13:00 (UTC -7)
Mexico City / Guatemala City / Juarez: 12:00 – 14:00 (UTC -6)
Bogota / Lima / Panama: 13:00 – 15:00 (UTC -5)
Santiago / Asunción / Santiago de los Caballeros: 14:00 – 16:00 (UTC -4)
Buenos Aires / São Paulo: 15:00 – 17:00 (UTC -3)
WELCOME + INTRODUCTION
Claudia de la Cruz, MD, Chile
GPA: Focus on Latin America
Claudia de la Cruz, MD, Chile
Genetic and Cultural Aspects of Psoriasis in Latin America
Angela Londoño, MSc, MD, Colombia
Pathophysiology and Therapeutic Targets
Margarita Velásquez Lopera, MD, PhD, Colombia
Clinical Manifestations of Psoriasis
Peter van de Kerkhof, MD, PhD, Netherlands
Psoriasis in Special Areas
Cristina Echeverría, MD, Argentina
CLOSING COMMENTS
Leandro Leite, MSc, MD, Brazil
WELCOME + INTRODUCTION
Leandro Leite, MSc, MD, Brazil
Overview of Psoriasis Comorbidities
Álvaro González-Cantero, MD, PhD, Spain
Psoriatic Arthritis for Dermatologists
André Lucas Ribeiro, MD, Brazil
Generalized Pustular Psoriasis
Ricardo Romiti, MD, PhD, Brazil
Pediatric Psoriasis
Enrique Rivas, MD, Guatemala
Clinical Case
CLOSING COMMENTS
Margarita Velásquez Lopera, MD, PhD, Colombia
WELCOME + INTRODUCTION
Margarita Velásquez Lopera, MD, PhD, Colombia
Treat to Target, Minimal Disease Activity, and Early Intervention
Ron Vender, MD, FRCPC, Canada
Topical Therapies and Phototherapy
Benjamin Hidalgo, MD, Costa Rica
Classical Systemic Therapies
Matías Maskin, MD, Argentina
Clinical Cases
CLOSING COMMENTS
Claudia de la Cruz, MD, Chile
WELCOME + INTRODUCTION
Claudia de la Cruz, MD, Chile
Overview of Biologics
Paolo Gisondi, MD, Italy
Anti TNF-a
Renata Magalhães, MD, PhD, Brazil
Anti IL 17, Anti IL12/23 and Anti IL-23
Leandro Leite, MSc, MD, Brazil
Screening and Monitoring Biologics
Tiago Torres, MD, PhD, Portugal
New Oral Therapies
Fernando Valenzuela, MD, Chile
CLOSING COMMENTS
Leandro Leite, MSc, MD, Brazil
WELCOME + INTRODUCTION
Margarita Velásquez Lopera, MD, PhD, Colombia
My Challenging Cases
César Gonzalez, MD, Colombia
André Carvalho, MD, PhD, Brazil
Clinical Cases
Q & A Session
All faculty
KEY LEARNING AND CLOSING COMMENTS
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
